Cargando…

Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch

Membranous nephropathy is an autoimmune kidney disease caused by autoantibodies targeting antigens present on glomerular podocytes, instigating a cascade leading to glomerular injury. The most prevalent circulating autoantibodies in membranous nephropathy are against phospholipase A2 receptor (PLA2R...

Descripción completa

Detalles Bibliográficos
Autores principales: Fresquet, Maryline, Lockhart-Cairns, Michael P., Rhoden, Samuel J., Jowitt, Thomas A., Briggs, David C., Baldock, Clair, Brenchley, Paul E., Lennon, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303975/
https://www.ncbi.nlm.nih.gov/pubmed/35858348
http://dx.doi.org/10.1073/pnas.2202209119
_version_ 1784751997559242752
author Fresquet, Maryline
Lockhart-Cairns, Michael P.
Rhoden, Samuel J.
Jowitt, Thomas A.
Briggs, David C.
Baldock, Clair
Brenchley, Paul E.
Lennon, Rachel
author_facet Fresquet, Maryline
Lockhart-Cairns, Michael P.
Rhoden, Samuel J.
Jowitt, Thomas A.
Briggs, David C.
Baldock, Clair
Brenchley, Paul E.
Lennon, Rachel
author_sort Fresquet, Maryline
collection PubMed
description Membranous nephropathy is an autoimmune kidney disease caused by autoantibodies targeting antigens present on glomerular podocytes, instigating a cascade leading to glomerular injury. The most prevalent circulating autoantibodies in membranous nephropathy are against phospholipase A2 receptor (PLA2R), a cell surface receptor. The dominant epitope in PLA2R is located within the cysteine-rich domain, yet high-resolution structure-based mapping is lacking. In this study, we define the key nonredundant amino acids in the dominant epitope of PLA2R involved in autoantibody binding. We further describe two essential regions within the dominant epitope and spacer requirements for a synthetic peptide of the epitope for drug discovery. In addition, using cryo-electron microscopy, we have determined the high-resolution structure of PLA2R to 3.4 Å resolution, which shows that the dominant epitope and key residues within the cysteine-rich domain are accessible at the cell surface. In addition, the structure of PLA2R not only suggests a different orientation of domains but also implicates a unique immunogenic signature in PLA2R responsible for inducing autoantibody formation and recognition.
format Online
Article
Text
id pubmed-9303975
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher National Academy of Sciences
record_format MEDLINE/PubMed
spelling pubmed-93039752022-07-23 Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch Fresquet, Maryline Lockhart-Cairns, Michael P. Rhoden, Samuel J. Jowitt, Thomas A. Briggs, David C. Baldock, Clair Brenchley, Paul E. Lennon, Rachel Proc Natl Acad Sci U S A Biological Sciences Membranous nephropathy is an autoimmune kidney disease caused by autoantibodies targeting antigens present on glomerular podocytes, instigating a cascade leading to glomerular injury. The most prevalent circulating autoantibodies in membranous nephropathy are against phospholipase A2 receptor (PLA2R), a cell surface receptor. The dominant epitope in PLA2R is located within the cysteine-rich domain, yet high-resolution structure-based mapping is lacking. In this study, we define the key nonredundant amino acids in the dominant epitope of PLA2R involved in autoantibody binding. We further describe two essential regions within the dominant epitope and spacer requirements for a synthetic peptide of the epitope for drug discovery. In addition, using cryo-electron microscopy, we have determined the high-resolution structure of PLA2R to 3.4 Å resolution, which shows that the dominant epitope and key residues within the cysteine-rich domain are accessible at the cell surface. In addition, the structure of PLA2R not only suggests a different orientation of domains but also implicates a unique immunogenic signature in PLA2R responsible for inducing autoantibody formation and recognition. National Academy of Sciences 2022-07-11 2022-07-19 /pmc/articles/PMC9303975/ /pubmed/35858348 http://dx.doi.org/10.1073/pnas.2202209119 Text en Copyright © 2022 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by/4.0/This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Biological Sciences
Fresquet, Maryline
Lockhart-Cairns, Michael P.
Rhoden, Samuel J.
Jowitt, Thomas A.
Briggs, David C.
Baldock, Clair
Brenchley, Paul E.
Lennon, Rachel
Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch
title Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch
title_full Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch
title_fullStr Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch
title_full_unstemmed Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch
title_short Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch
title_sort structure of pla2r reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch
topic Biological Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303975/
https://www.ncbi.nlm.nih.gov/pubmed/35858348
http://dx.doi.org/10.1073/pnas.2202209119
work_keys_str_mv AT fresquetmaryline structureofpla2rrevealspresentationofthedominantmembranousnephropathyepitopeandanimmunogenicpatch
AT lockhartcairnsmichaelp structureofpla2rrevealspresentationofthedominantmembranousnephropathyepitopeandanimmunogenicpatch
AT rhodensamuelj structureofpla2rrevealspresentationofthedominantmembranousnephropathyepitopeandanimmunogenicpatch
AT jowittthomasa structureofpla2rrevealspresentationofthedominantmembranousnephropathyepitopeandanimmunogenicpatch
AT briggsdavidc structureofpla2rrevealspresentationofthedominantmembranousnephropathyepitopeandanimmunogenicpatch
AT baldockclair structureofpla2rrevealspresentationofthedominantmembranousnephropathyepitopeandanimmunogenicpatch
AT brenchleypaule structureofpla2rrevealspresentationofthedominantmembranousnephropathyepitopeandanimmunogenicpatch
AT lennonrachel structureofpla2rrevealspresentationofthedominantmembranousnephropathyepitopeandanimmunogenicpatch